University of Oregon

John Andrew Berglund

Michael M Haley

M Bryan Warf

Cameron L Hilton

Catherine Matthys

Methods are provided herein for treatment of myotonic dystrophy and other toxic RNA diseases in a subject. In some examples, the method comprises administration of a compound that binds a nucleotide repeat expansion in a ribonucleic acid molecule, thereby treating the disease. In additional examples, the method comprises administration of a compound that disrupts binding of muscleblind-like proteins to an RNA nucleotide repeat expansion. Compounds for use in the disclosed method include pentamidine or heptamidine or derivatives thereof. Representative compounds are described herein.

Growing community of inventors

Eugene, OR, United States of America

John Andrew Berglund